Severe sepsis and septic shock in the emergency department

被引:27
作者
Talan, David A. [1 ,2 ,3 ]
Moran, Gregory J. [1 ,2 ,3 ]
Abrahamian, Fredrick M. [2 ,3 ]
机构
[1] Olive View UCLA Med Ctr, Dept Emergency Med, Sylmar, CA 91342 USA
[2] Olive View UCLA Med Ctr, Dept Med, Div Infect Dis, Sylmar, CA 91342 USA
[3] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
关键词
D O I
10.1016/j.idc.2007.09.005
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Increased attention has focused recently on the acute management of severe sepsis and septic shock, conditions that represent the end-stage systemic deterioration of overwhelming infection. Clinical trials have identified new therapies and management approaches that, when applied early, appear to reduce mortality. Practice guidelines have been advanced by critical care societies, and many of the proposed interventions involve therapies other than antimicrobials directed at hemodynamic resuscitation or addressing adverse effects of the inflammatory cascade. Although many emergency departments (EDs) are now adopting treatment protocols for sepsis that are based on published treatment guidelines, recent research calls many of the initial recommendations into question, and validation trials of some of these approaches are ongoing. This article reviews the initial evaluation and treatment considerations of sepsis in the ED setting. © 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:1 / 31
页数:31
相关论文
共 143 条
[1]   EFFICACY AND SAFETY OF MONOCLONAL-ANTIBODY TO HUMAN TUMOR-NECROSIS-FACTOR-ALPHA IN PATIENTS WITH SEPSIS SYNDROME - A RANDOMIZED, CONTROLLED, DOUBLE-BLIND, MULTICENTER CLINICAL-TRIAL [J].
ABRAHAM, E ;
WUNDERINK, R ;
SILVERMAN, H ;
PERL, TM ;
NASRAWAY, S ;
LEVY, H ;
BONE, R ;
WENZEL, RP ;
BALK, R ;
ALLRED, R ;
PENNINGTON, JE ;
WHERRY, JC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 273 (12) :934-941
[2]  
Abraham E, 1998, LANCET, V351, P929
[3]   Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death [J].
Abraham, E ;
Laterre, P ;
Garg, R ;
Levy, H ;
Talwar, D ;
Trzaskoma, BL ;
Francois, B ;
Guy, JS ;
Bruckmann, M ;
Rea-Neto, A ;
Rossaint, R ;
Perrotin, D ;
Sablotzki, A ;
Arkins, N ;
Utterback, BG ;
Macias, WL .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (13) :1332-1341
[4]   LACTATE CLEARANCE AND SURVIVAL FOLLOWING INJURY [J].
ABRAMSON, D ;
SCALEA, TM ;
HITCHCOCK, R ;
TROOSKIN, SZ ;
HENRY, SM ;
GREENSPAN, J .
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 1993, 35 (04) :584-589
[5]  
*AC RESP DISTR SYN, 2000, NEW ENGL J MED, V342, P1301, DOI DOI 10.1056/NEJM200005043421801
[6]   Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care [J].
Angus, DC ;
Linde-Zwirble, WT ;
Lidicker, J ;
Clermont, G ;
Carcillo, J ;
Pinsky, MR .
CRITICAL CARE MEDICINE, 2001, 29 (07) :1303-1310
[7]   A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin [J].
Annane, D ;
Sébille, V ;
Troché, G ;
Raphaël, JC ;
Gajdos, P ;
Bellissant, E .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (08) :1038-1045
[8]   Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock [J].
Annane, D ;
Sébille, V ;
Charpentier, C ;
Bollaert, PE ;
François, B ;
Korach, JM ;
Capellier, G ;
Cohen, Y ;
Azoulay, E ;
Troché, G ;
Chaumet-Riffaut, P ;
Bellissant, E .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (07) :862-871
[9]   BAND NEUTROPHIL COUNTS ARE UNNECESSARY FOR THE DIAGNOSIS OF INFECTION IN PATIENTS WITH NORMAL TOTAL LEUKOCYTE COUNTS [J].
ARDRON, MJ ;
WESTENGARD, JC ;
DUTCHER, TF .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1994, 102 (05) :646-649
[10]   Community-acquired bacterial meningitis: Risk stratification for adverse clinical outcome and effect of antibiotic timing [J].
Aronin, SI ;
Peduzzi, P ;
Quagliarello, VJ .
ANNALS OF INTERNAL MEDICINE, 1998, 129 (11) :862-869